4//SEC Filing
Ettenberg Seth 4
Accession 0001209191-18-052358
CIK 0001622229other
Filed
Sep 25, 8:00 PM ET
Accepted
Sep 26, 6:41 PM ET
Size
9.4 KB
Accession
0001209191-18-052358
Insider Transaction Report
Form 4
Ettenberg Seth
Chief Scientific Officer
Transactions
- Exercise/Conversion
Common Stock
2018-09-25$0.18/sh+11,485$2,067→ 11,485 total - Sale
Common Stock
2018-09-25$12.47/sh−11,485$143,181→ 0 total - Exercise/Conversion
Stock Option (Right to Buy)
2018-09-24−11,485→ 386,570 totalExercise: $0.18Exp: 2025-01-28→ Common Stock (11,485 underlying)
Footnotes (3)
- [F1]The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.
- [F2]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $12.11 to $12.90, inclusive. The reporting person undertakes to provide to Unum Therapeutics Inc., any security holder of Unum Therapeutics Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
- [F3]25% of the shares vests on September 3, 2015, and the remaining shares shall vest in 36 equal monthly installments thereafter, subject to the Reporting Persons continuous service with the Issuer.
Documents
Issuer
Unum Therapeutics Inc.
CIK 0001622229
Entity typeother
Related Parties
1- filerCIK 0001734419
Filing Metadata
- Form type
- 4
- Filed
- Sep 25, 8:00 PM ET
- Accepted
- Sep 26, 6:41 PM ET
- Size
- 9.4 KB